21 May 2013
Keywords: procept, anti-hiv, drug, phase, i/ii, specialist, immune
Article | 04 September 1995
Specialist in immune system therapeutics Procept has started Phase I/II clinical trials for its leading drug candidate PRO 2000, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.